X
01Jul

Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)

At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China.  Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/novartis-and-alcon-fcpa-enforcement-13538/

Related

Maryland Workers' Compensation: Idiosyncrasies of Permanent Partial Disability Awards

Once the claimant’s condition is at maximum medical improvement, the Maryland statute provides for ...

Read More >

NLRB Proposes Rulemaking to Protect Employee Free Choice

On Friday, August 9, 2019, the National Labor Relations Board (“NLRB” or “Board”) issued its fir...

Read More >

Ongoing Developments: CORONAVIRUS UPDATE

Given the ongoing developments with the Coronavirus outbreak, we want to provide you with simple pro...

Read More >

AB 5 Becomes Law: California Limits the use of Independent Contractors by Employers

On September 18, 2019, Governor Newsom signed Assembly Bill 5, thereby establishing a law that purpo...

Read More >

Sexual Harassment In The Workplace: What Hungarian Companies Need To Know

What constitutes sexual harassment? In the Hungarian law, sexual harassment is covered by the gener...

Read More >

Earn-Out Provision Of Merger Agreement Requires Extrinsic Evidence To Aid Interpretation

In Western Standard, LLC, v. SourceHOV Holdings, Inc. and Pangea Acquisitions, Inc., C.A. No. 2018-0...

Read More >